Brief curriculum vitae
Dr. Maria Pavlatou is an Endocrinologist – Diabetologist with extensive postgraduate training in the USA and comprehensive professional experience at the world’s leading research hospital National Institutes of Health (NIH) and other world-class hospitals in the USA and England.
In 2001 she graduated from the Medical School of the Democritus University of Thrace, and in 2008 she became a Doctor of Medicine of the National and Kapodistrian University of Athens.
She was trained through a US government scholarship and worked alongside leading scientists at the National Institutes of Health (NIH) and the Perinatology Research Branch of NICHD/NIH at the Wayne State University School of Medicine.
Subsequently, she was awarded the UEMS European Exchange in Endocrinology Expertise Fellowship and worked as Consultant in Endocrinology, Diabetes and Internal Medicine for the National Health Service (NHS) in England at the Royal Victoria Infirmary and the Freeman Hospital & General Hospital (Newcastle Hospitals), William Harvey Hospital (East Kent) and James Cook University Hospital (Middlesbrough).
In 2018 she received a tenure offer to the post of Consultant in Endocrinology, Diabetes and Internal Medicine at St. James’s University Hospital (Leeds) and in 2019 she decided to return and offer her services in Greece.
Since 2019, she has been Director of Endocrinology, Diabetes and Metabolism at the Athens Medical Center.
Her goal is to practice of modern, evidence-based medicine, in order to help Greece to adopt and implement the latest developments and most advanced scientific knowledge in Endocrinology.
Detailed Curriculum Vitae
ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ
Dr. Maria Pavlatou MD, PhD Endocrinologist – Diabetologist
SPECIALTY
Endocrinology, Diabetes Mellitus and Metabolism
- Neuroendocrinology, Endocrine and Neuroendocrine Tumors
- Gynecological and Reproductive Endocrinology, Diabetes and Endocrinology of Pregnancy
- Endocrinology, Diabetes and Endocrinology of Pregnancy
- Diabetes and Obesity
TITLES OF STUDY
21 April 2016:
Title and license of Medical Specialty Endocrinology, Diabetes Mellitus and Metabolism, Region of Attica, Department of Public Health.
20 February 2008:
Doctor of Medicine, Ph.D. Thesis Title, Subject: “The Adrenal Axis in Diabetes.” Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Aghia Sophia Children’s Hospital, Adult Diabetes Clinic, First Department of Propeadeutic and Internal Medicine, Laikon Hospital, Chair: Professor George P. Chrousos, National and Kapodistrian University of Athens, Medical School.
11 July 2001:
Doctor of Medicine, M.D., Democritus University of Thrace, Medical School.
FELLOWSHIP IN ENDOCRINOLOGY, DIABETES MELLITUS AND METABOLISM
07/2008 – 07/2010:
04/2006 – 04/2008:
National and Kapodistrian University of Athens, Medical School, Greece. Clinical Fellowship Program in Endocrinology. Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Aghia Sophia Children’s Hospital, Adult Endocrine Unit,Evgenidion Hospital.
DOCTORAL THESIS-DOCTOR OF PHILOSOPHY IN MEDICINE, Ph.D.
10/2003 – 02/2008:
National and Kapodistrian University of Athens, Medical School, Greece. Ph.D. Dissertation Subject: “The Adrenal Axis in Diabetes.” Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Children’s Hospital “Aghia Sophia”, Adult Diabetes Clinic, First Department of Propaedeutic and Internal Medicine, Hospital “Laiko”, Chair: Professor George P. Chrousos.
RESIDENCY IN INTERNAL MEDICINE
05/2004 – 02/2006:
GENERAL MEDICINE COMPULSORY SERVICE
09/2001 – 12/2002:
MEDICAL DEGREE-DOCTOR OF MEDICINE, M.D.:
10/1995-07/2001:
WORK EXPERIENCE & POSTDOCTORAL TRAINING
01/2019–present:
Director of Endocrinology, Diabetes and Metabolism. Neuroendocrinology, Neuroendocrine and Endocrine Tumors, Thyroid cancer, Gynecological Endocrinology-Gynecological Endocrinology, Endocrinology of Pregnancy, Transitional Endocrinology, Athens Medical Center, “Iatriko”, Greece.
05/2018:
Tenure-track offer after interview for the post of Consultant in Diabetes, Endocrinology and General Internal Medicine. Centre for Endocrinology and Diabetes, St. James’ University Hospital, The Leeds Teaching Hospitals NHS Foundation Trust, National Health Service (NHS), UK.
11/2017 – 11/2018:
Locum Consultant in Endocrinology, Diabetes and General Internal Medicine, Endocrine and Diabetes Unit, Royal Victoria Infirmary, Freeman & General Hospitals, Newcastle upon Tyne Hospitals NHS Foundation Trust, University of Newcastle upon Tyne, National Health Service England (NHS), UK.
04 – 09/2017:
Locum Consultant in Endocrinology, Diabetes and General Internal Medicine, Endocrine and Diabetes Unit, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, and James Cook University Hospital, South Tees NHS Foundation Trust, National Health Service England (NHS), UK.
11/2016 – 04/2017:
Honorary Fellow in Medicine, UEMS Exchange in Endocrinology Expertise, Endocrine and Diabetes Unit, Royal Victoria Infirmary and Freeman Hospitals, Newcastle upon Tyne Hospitals NHS Foundation Trust, University of Newcastle upon Tyne, National Health Service (NHS), UK.
09/2013 – 06/2016:
Scientific Associate, National and Kapodistrian University of Athens, Medical School, Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieio Hospital, Greece.
04/2012 – 07/2013:
Research Associate, Wayne State University, USA. Program in Perinatal Research and Obstetrics, Perinatology Research Branch, Maternal-Fetal Medicine, National Institute of Child Health and Human Development (NICHD/NIH), Hutzel Women’s Hospital, School of Medicine, Wayne State University, Detroit, Michigan, USA.
07/2008 – 07/2013:
Post-Doctoral Visiting Fellow w/ Clinical Privileges, National Institutes of Health (NIH), USA. Clinical & Research Fellowship Program in Adult and Reproductive Endocrinology, Section on Medical Neuroendocrinology, Developmental Endocrine Oncology and Genetics, National Institute of Child Health and Human Development (NICHD/NIH), Clinical Neuroendocrinology Branch, National Institute of Mental Health (NIMH/NIH), Department of Laboratory Medicine, Special Chemistry Laboratory & Mass Spectrometry, NIH Clinical Center, Bethesda, Maryland, USA.
POSTDOCTORAL COURSES-NATIONAL INSTITUTES OF HEALTH (NIH), USA
11/2012:
Certificate of Completion, Compliance Training, Wayne State University, Detroit, Michigan, USA.
07/2010:
Certificate of Completion, Radiation Safety in Laboratory Training, Division of Radiation Safety (DRS), National Institutes of Health (NIH), Bethesda, Maryland, USA.
06/2010:
Certificate of Completion, Contamination Control Training, Division of Radiation Safety, National Institutes of Health (NIH), Bethesda, Maryland, USA.
06/2010:
Certificate of Completion, Radiation Safety Orientation Training, Division of Radiation Safety, (DRS), National Institutes of Health (NIH), Bethesda, Maryland, USA.
06/2010:
LC/MS User Meeting, Agilent/LC/MS two-day conference – Workshop User on QQQ LC/MS (Day 1), and Workshop User on TOF-Q-TOF LC/MS (Day 2), Gerstel, Inc. on June 22-23, Linthicum, Maryland, USA.
06/2010:
03/2010:
Mass-Spectrometry Hands-on & Theory on QQQ & QTF by Agilent, Delaware, USA.
03/2010:
Mass-Spectrometry and Proteomics, Pharma Cadence, March 12-23, Philadelphia, USA.
03/2010:
Mass-Spectrometry Hands-on & Theory on QQQ by Agilent, Department of Laboratory Medicine, Special Chemistry Laboratory & Mass-Spectrometry, National Institutes of Health (NIH), Clinical Center, Bethesda, Maryland, USA.
09/2009:
A Review of Endocrinology: Diagnosis and Treatment, the Foundation for Advanced Education in the Sciences (FAES) graduate school, the National Institutes of Health(NIH), and the George Washington University Medical Center, September 8-12, 2009, Bethesda, Maryland, USA.
04/2009:
Certificate of Completion, Mouse Workshop, Office of Animal Care and Use (OACU), National Institutes of Health (NIH), Bethesda, Maryland, USA.
04/2009:
Certificate of Completion, Working Safely with HIV & other Bloodborne Pathogens Safety, Division of Occupational Health and Safety (DOHS), National Institutes of Health (NIH), Bethesda, Maryland, USA.
03/2009:
Certificate of Completion, Guidelines for Animal Users, Office of Animal Care and Use (OACU), National Institutes of Health (NIH), Bethesda, Maryland, USA.
01/2009:
Certificate of Completion, Short-term Course in Human Embryonic Stem Cell Culture, Stem Cell Biology Research, Johns Hopkins University, January 12-16, 2009, Baltimore, Maryland, USA.
09 – 12/2008:
Certificate of Completion, Stem cells and their Niches: Jump Start for University Teaching, Foundation for Advanced Education in the Sciences, (FAES), September 15 – December 19, National Institutes of Health (NIH), Bethesda, Maryland, USA.
09 – 12/2008:
12/2008:
12/2008:
Certificate of Completion, Clinical Research Information System (CRIS) Training, Department of Clinical Research Informatics (DCRI), National Institutes of Health (NIH), Clinical Center, Bethesda, Maryland, USA.
07 – 08/2007:
Adjunct Scientist, National Institutes of Health (NIH), Bethesda, Maryland, USA, Bench Research on the Glucocorticoid Receptor Signalling System at the Reproductive Biology and Medicine Branch (RBMB), Eunice Kennedy Shriver, National Institute of Child Health and Human Development (NICHD/NIH), Bench Research on the Neural Stem Cell Biology at the Molecular Biology Laboratory, National Institute of Neurological Disorders and Stroke (NINDS/NIH).
POST-GRADUATE COURSES
10/2023:
10/2022:
11/2021:
01/2020:
10/2016:
01/2014:
02 – 03/2007:
2004 – 2005:
12/2004:
11/2004:
07/2004:
PARTICIPATION IN CLINICAL TRIALS
2016-2017
“MEREO Hypogonadal Study”, National Institute for Health Research (NIHR), Newcastle Clinical Research Facility (CRF), Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust.
HONORS, AWARDS, DISTINCTIONS, GRANTS & SCHOLARSHIPS
01/2016:
06/2012 – 08/2013:
07/2011 – 06/2012:
07/2010 – 07/2011:
07/2008 – 07/2010:
07/2009:
01/2007:
MANAGEMENT SKILLS-MULTIDISCIPLINARY TEAM MEETINGS
01/2019–present:
11/2017 – 11/2018:
Outpatients clinics: Joint Endocrine Clinic, Rapid Access Clinic, Antenatal Joint Clinic, Diabetic Clinic, Neuroendocrine Tumor (NET) Clinic
Multidisciplinary Team (MDT) Meetings, Neuroendocrine Tumor (NET), Thyroid Cancer and Endocrine Multiple Disciplinary Team Meetings, Endocrine and Diabetes Unit, Royal Victoria Infirmary, Freeman and General Hospitals, Newcastle Upon Tyne Hospitals NHS Foundation Trust, University of Newcastle upon Tyne, NHS, UK
04 – 09/2017:
PROFESSIONAL LICENCES
11/2016-present:
04/2016:
08/2001-present:
MEMBERSHIP IN SCIENTIFIC SOCIETIES
- General Medical Council (UK)
- Athens Medical Association (Greece)
- Hellenic Endocrinology Society (Greece)
EDITORIAL ACTIVITIES
- Clinical Endocrinology (Reviewer)
- Metabolism (Reviewer)
- Clinical Biochemistry (Reviewer)
- American Journal of Obstetrics and Gynaecology (Reviewer)
- Journal of Endocrinological Investigation (Reviewer)
TEACHING EXPERIENCE
11/2017 – 11/2018:
04 – 09/2017:
09 – 12/2008:
LANGUAGES
07/2016:
06/2004:
10/1991:
PRESENTATIONS AT INTERNATIONAL MEETINGS
- Endocrine Society’s 94th Annual Meeting: Endo 2012. Houston, TX. “Haploinsufficiency May Explain Partial Glucocorticoid, Androgen, and, Thyroid Hormone Resistance Associated with 16p11.2 Microdeletion”.
- Endocrine Society’s 93th Annual Meeting: Endo 2011. Boston, MA. “Circulating Cortisol- Associated Signature of Glucocorticoid-related Gene Expression in Subcutaneous Fat of Obese Subjects”.
- European Association for the Study of Diabetes: 44th Annual Meeting 2008. Rome. “Fort and Ford: Two Novel Assays for the Assessment of Oxidative Stress in Patients with Newly Diagnosed Diabetes Mellitus Type 2”.
- Endocrine Society’s 89th Annual Meeting: Endo 2007. Toronto. “Chronic Angiotensin II Receptor Antagonism Increases Retinol-Binding Protein 4, Improves Metabolic Profile’s and Inflammation’s Markers and Resets the Hypothalamic-Pituitary-Adrenal Axis of Patients with Diabetes Mellitus Type 2: A Pilot Study”.
- Endocrine Society’s 88th Annual Meeting: Endo 2006. Boston, MA. “Angiotensin II Receptor Antagonist Therapy Suppresses Hypothalamic Pituitary Adrenal Axis Function in Patients with Impaired Glucose Tolerance and Diabetes Mellitus Type.”
«INVITED SPEACHES»
- “Functional Adrenal Neoplasms”. Continuous Medical Education, Athens Medical Center, 2 February 2022, Athens, Greece.
- “Endocrine Disorders in Pregnancy”. Continuous Medical Education, Athens Medical Center, 19 May 2021, Athens, Greece.
- “Sexual Dysfunction, Endocrine Approach”, Athens Medical Center, 26 May 2021, Athens, Greece.
- “The Diabetic Patient with Cardiovascular Disease. Newer Therapeutical Choices”. Research Institute for Longevity and Prevention of Senescence Diseases, Developments in Cardiovascular Medicine, 5-7 December 2019, Athens, Greece.
- “Neuroendocrine Tumors”. Continuous Medical Education, Athens Medical Center, 29 January 2020, Athens, Greece.
- “Calcium and Calcium Regulating Hormones in Depressive Illness. The role of Klotho, Vitamin D and Regulated Molecules”. Program in Perinatal Research and Obstetrics, Perinatology Research Branch, Maternal-Fetal Medicine, National Institute of Child Health and Human Development (NICHD/NIH), Hutzel Women’s Hospital, School of Medicine, Wayne State University, Detroit, Michigan.
PUBLICATIONS
- Dimitra Pappa, Maria G. Pavlatou, Katerina Skenderi, Maria Papastamataki, George Mastorakos, George P. Chrousos, Maria Tsironi, and Ioannis Papassotiriou. “Effect of an ultra-distance foot race on the hypothalamic-pituitary testicular adrenocortical axes insulin growth factor levels: distinct patterns of suppression, stimulation and recovery”. Ann Res Hosp. 2019 Feb 03; 3:5.
- Maria G. Pavlatou, Remaley A.T, Gold P.W. “Klotho: A Humeral Mediator in CSF and Plasma that Influences Longevity and Susceptibility to Multiple Complex Disorders, Including Depression.” Transl. Psychiatry. 2016 Aug 30; 6(8): e876.
- Luiz HV, Tanchee MJ, Pavlatou MG, Yu R, Nambuba J, Wolf K, Prodanov T, Wesley R, Adams K, Fojo T, Pacak K. “Are patients with hormonally functional pheochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.” Clin Endocrinol (Oxf). 2016 Jul; 85(1): 62-9.
- Gold PW, Pavlatou MG, Michelson D, Mouro CM, Kling MA, Wong ML, Licinio J, Goldstein SA. “Chronic Administration of Anticonvulsants but not Antidepressants Impairs Bone Strength: Clinical Implications.” Transl Psychiatry. 2015 June; e576.
- Gold PW, Machado-Vieira R, Pavlatou MG. “Clinical and Biochemical Manifestations of Depression: Relation to the Neurobiology of Stress.” Neural Plast. 2015 March; 581976.
- Maria G. Pavlatou, Kasey C. Vickers, Sudhir Varma, Rana Malek, Maureen Sampson, Alan T. Remaley, Philip W. Gold, Monica C. Skarulis, Tomoshige Kino. “Circulating Cortisol-Associated Signature of Glucocorticoid-related Gene Expression in Subcutaneous Fat of Obese Subjects.” Obesity (Silver Spring). 2013 May; 21(5): 960–967.
- Philip W. Gold, Licinio J, Pavlatou MG. “Pathological Parainflammation and Endoplasmic Reticulum Stress in Depression: Potential Translational Targets through the CNS Insulin, Klotho and PPAR-γ Systems.” Mol. Psychiatry 2013 18, 154–165.
- Gold PW, Pavlatou MG, Carlson PJ, Luckenbaugh DA, Costello R, Bonne O, Csako G, Drevets WC, Remaley AT, Charney DS, Neumeister A, Kling MA. “Unmedicated, Remitted Patients with Major Depression Have Decreased Serum Immunoglobulin A.” Neurosci. Lett. 2012 June; 1-5
- Kino T*, Pavlatou MG*, Moraitis AG, Nemery RL, Raygada M, Stratakis CA. “ZNF764 Haploinsufficiency May Explain Partial Glucocorticoid, Androgen, and Thyroid Hormone Resistance Associated with 16p11.2 Microdeletion.” JCEM 2012; E1557-66. *These authors contributed equally to this work.
- Maria G. Pavlatou, George Mastorakos, Alexandra Margeli, Evangelia Kouskouni, Nicholas Tentolouris, Nikos Katsilambros, George P. Chrousos and Ioannis Papassotiriou. “Angiotensin Blockade in Diabetic Patients Decreases Insulin Resistance-Associated Low-Grade Inflammation.” EJCI 2010 Dec; 652-8.
- Maria G. Pavlatou, Maria Papastamataki, Filia Apostolakou, Ioannis Papassotiriou, Nicholas Tentolouris. “FORT and FORD: 2 Simple and Rapid Assays in the Evaluation of Oxidative Stress in Patients with Type 2 Diabetes Mellitus.” Metabolism 2009 Nov; 1657-62.
- Maria G. Pavlatou, Mastorakos G, Lekakis I, Liatis S, Vamvakou G, Zoumakis E, Papassotiriou I, Rabavilas AD, Katsilambros N, Chrousos GP. “Chronic Administration of an Angiotensin II Receptor Antagonist Resets the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Improves the Affect of Patients with Diabetes Mellitus Type 2: Preliminary Results.” Stress 2007 Jul: 1-11.
- Mastorakos G., Pavlatou MG, M Mizamtsidi. “The Hypothalamic-Pituitary-Adrenal and the Hypothalamic-Pituitary- Gonadal axes Interplay.” Pediatric Endocrinology Reviews Jan 2006, 1; 172-182.
- Mastorakos G., Pavlatou M. “Exercise as a Stress Model and the Interplay between the Hypothalamic Pituitary-Adrenal and the Hypothalamic-Pituitary-Thyroid Axes.” Hormone and Metabolic Research, Sept 2005, 37 (9); 577-584.
- Mastorakos G., Pavlatou M., E. Diamanti-Kandarakis, G.P. Chrousos. “Exercise and the Stress System.” Hormones (Athens), 2005 April-June, 4(2): 73-89.
- Mastorakos G., Pavlatou M. “Exercise and the Stress System.” Obstetricia Ginecologia. 2004 Jul, Νο 4.
BOOK CHAPTERS
- Maria G Pavlatou, Sarah J Johnson, Petros Perros. Practical Management of Thyroid Cancer ‐ A Multidisciplinary Approach, Second edition. Springer Nature. 2018
- Mastorakos G., MG. Pavlatou. “Exercise and Female Endocrine Regulations.” In press.
- Mastorakos G., MG. Pavlatou, N. Salakos. “The Mechanisms of Stress in Athletes.” Athens, 2007; 12.
- Mastorakos G., MG. Pavlatou, and I. Ilias. “Hypothalamic-Pituitary-Adrenal axis and the Gonadal axis” in the book: “Reproductive Endocrinology in Woman and Man.” Thessaloniki, 2004; 31:481-497.
